Expression and purification of the Mycobacterium tuberculosis complex-restricted antigen CFP21 to study its immunoprophylactic potential in mouse model

Protein Expression and Purification

Volumn 48, Issue 2, 2006, Pages 274-280

  Grover, Ajay ^a   Ahmed, Mir Fayaz ^b   Verma, Indu ^a   Sharma, Pawan ^b   Khuller, G K ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

^b INTERNATIONAL CENTRE FOR GENETIC ENGINEERING AND BIOTECHNOLOGY   (Italy)

Author keywords

CFP21; Culture filtrate proteins; Mycobacterium tuberculosis; Regions of difference; Subunit vaccine

Indexed keywords

BACTERIAL ANTIGEN; HYBRID PROTEIN;

ANIMAL; ANIMAL MODEL; ARTICLE; BIOLOGICAL MODEL; BIOSYNTHESIS; C57BL MOUSE; DISEASE MODEL; ESCHERICHIA COLI; GENE EXPRESSION; GENETICS; IMMUNOLOGY; ISOLATION AND PURIFICATION; MOUSE; MYCOBACTERIUM TUBERCULOSIS; PHYLOGENY; TUBERCULOSIS;

ANIMALS; ANTIGENS, BACTERIAL; DISEASE MODELS, ANIMAL; ESCHERICHIA COLI; GENE EXPRESSION; MICE; MICE, INBRED C57BL; MODELS, ANIMAL; MODELS, IMMUNOLOGICAL; MYCOBACTERIUM TUBERCULOSIS; PHYLOGENY; RECOMBINANT FUSION PROTEINS; TUBERCULOSIS;

ESCHERICHIA COLI; MYCOBACTERIUM TUBERCULOSIS; MYCOBACTERIUM TUBERCULOSIS COMPLEX;

EID: 33746239102     PISSN: 10465928     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pep.2006.03.010     Document Type: Article

References (28)

1. Kaufmann S.H. Is the development of a new tuberculosis vaccine possible?. Nat. Med. 6 (2000) 955-960
2. Cole S.T., Brosch R., Parkhill J., Garnier T., Churcher C., Harris D., Gordon S.V., Eiglmeier K., Gas S., Barry III C.E., Tekaia F., Badcock K., Basham D., Brown D., Chillingworth T., Connor R., Davies R., Devlin K., Feltwell T., Gentles S., Hamlin N., Holroyd S., Hornsby T., Jagels K., Krogh A., McLean J., Moule S., Murphy L., Oliver K., Osborne J., Quail M.A., Rajandream M.A., Rogers J., Rutter S., Seeger K., Skelton J., Squares R., Squares S., Sulston J.E., Taylor K., Whitehead S., and Barrell B.G. Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature 393 (1998) 537-544
3. Horwitz M.A., Lee B.W., Dillon B.J., and Harth G. Protective immunity against tuberculosis induced by vaccination with major extracellular proteins of Mycobacterium tuberculosis. Proc. Natl. Acad. Sci. USA 92 (1995) 1530-1534
4. Brandt L., Elhay M., Rosenkrands I., Lindblad E.B., and Andersen P. ESAT-6 subunit vaccination against Mycobacterium tuberculosis. Infect. Immun. 68 (2000) 791-795
5. Lowrie D.B., Tascon R.E., Bonato V.L., Lima V.M., Faccioli L.H., Stavropoulos E., Colston M.J., Hewinson R.G., Moelling K., and Silva C.L. Therapy of tuberculosis in mice by DNA vaccination. Nature 400 (1999) 269-271
6. Kamath A.T., Feng C.G., Macdonald M., Briscoe H., and Britton W.J. Differential protective efficacy of DNA vaccines expressing secreted proteins of Mycobacterium tuberculosis. Infect. Immun. 67 (1999) 1702-1707
7. Mahairas G.G., Sabo P.J., Hickey M.J., Singh D.C., and Stover C.K. Molecular analysis of genetic differences between Mycobacterium bovis BCG and virulent M. bovis. J. Bacteriol. 178 (1996) 1274-1282
8. Behr M.A., Wilson M.A., Gill W.P., Salamon H., Schoolnik G.K., Rane S., and Small P.M. Comparative genomics of BCG vaccines by whole-genome DNA microarray. Science 284 (1999) 1520-1523
9. Bao L., Chen W., Zhang H., and Wang X. Virulence, immunogenicity, and protective efficacy of two recombinant Mycobacterium bovis bacillus Calmette-Guerin strains expressing the antigen ESAT-6 from Mycobacterium tuberculosis. Infect. Immun. 71 (2003) 1656-1661
10. Pym A.S., Brodin P., Majlessi L., Brosch R., Demangel C., Williams A., Griffiths K.E., Marchal G., Leclerc C., and Cole S.T. Recombinant BCG exporting ESAT-6 confers enhanced protection against tuberculosis. Nat. Med. 9 (2003) 533-539
11. Arend S.M., Geluk A., van Meijgaarden K.E., van Dissel J.T., Theisen M., Andersen P., and Ottenhoff T.H. Antigenic equivalence of human T-cell responses to Mycobacterium tuberculosis-specific RD1-encoded protein antigens ESAT-6 and culture filtrate protein 10 and to mixtures of synthetic peptides. Infect. Immun. 68 (2000) 3314-3321
12. Elhay M.J., Oettinger T., and Andersen P. Delayed-type hypersensitivity responses to ESAT-6 and MPT64 from Mycobacterium tuberculosis in the guinea pig. Infect. Immun. 66 (1998) 3454-3456
13. Olsen I., Reitan L.J., and Wiker H.G. Distinct differences in repertoires of low-molecular-mass secreted antigens of Mycobacterium avium complex and Mycobacterium tuberculosis. J. Clin. Microbiol. 38 (2000) 4453-4458
14. Morris S., Kelley C., Howard A., Li Z., and Collins F. The immunogenicity of single and combination DNA vaccines against tuberculosis. Vaccine 18 (2000) 2155-2163
15. Weldingh K., Rosenkrands I., Jacobsen S., Rasmussen P.B., Elhay M.J., and Andersen P. Two-dimensional electrophoresis for analysis of Mycobacterium tuberculosis culture filtrate and purification and characterization of six novel proteins. Infect. Immun. 66 (1998) 3492-3500
16. Weldingh K., and Andersen P. Immunological evaluation of novel Mycobacterium tuberculosis culture filtrate proteins. FEMS Immunol. Med. Microbiol. 23 (1999) 159-164
17. Gamieldien J., Ptitsyn A., and Hide W. Eukaryotic genes in Mycobacterium tuberculosis could have a role in pathogenesis and immunomodulation. Trends. Genet. 18 (2002) 5-8
18. Demissie A., Ravn P., Olobo J., Doherty T.M., Eguale T., Geletu M., Hailu W., Andersen P., and Britton S. T-cell recognition of Mycobacterium tuberculosis culture Filtrate fractions in tuberculosis patients and their household contacts. Infect. Immun. 67 (1999) 5967-5971
19. Ravn P., Demissie A., Eguale T., Wondwosson H., Lein D., Amoudy H.A., Mustafa A.S., Jensen A.K., Holm A., Rosenkrands I., Oftung F., Olobo J., von Reyn F., and Andersen P. Human T cell responses to the ESAT-6 antigen from Mycobacterium tuberculosis. J. Infect. Dis. 179 (1999) 637-645
20. Vekemans J., Lienhardt C., Sillah J.S., Wheeler J.G., Lahai G.P., Doherty M.T., Corrah T., Andersen P., McAdam K.P., and Marchant A. Tuberculosis contacts but not patients have higher gamma interferon responses to ESAT-6 than do community controls in The Gambia. Infect. Immun. 69 (2001) 6554-6557
21. Kolattukudy P.E., Purdy R.E., and Maiti I.B. Cutinase from fungi and pollen. Methods Enzymol. 71 (1981) 652-664
22. Denis O., Lozes E., and Huygen K. Induction of cytotoxic T-cell responses against culture filtrate antigens in Mycobacterium bovis bacillus Calmette-Guerin-infected mice. Infect. Immun. 65 (1997) 676-684
23. Weber M., Moller K., Welzeck M., and Schorr J. Short technical reports. Effects of lipopolysaccharide on transfection efficiency in eukaryotic cells. Biotechniques 19 (1995) 930-940
24. Leal I.S., Smedegard B., Andersen P., and Appelberg R. Interleukin-6 and interleukin-12 participate in induction of a type 1 protective T-cell response during vaccination with a tuberculosis subunit vaccine. Infect. Immun. 67 (1999) 5747-5754
25. Singh H., and Raghava G.P. ProPred: prediction of HLA-DR binding sites. Bioinformatics 17 (2001) 1236-1237
26. Andersen P. TB vaccines: progress and problems. Trends. Immunol. 22 (2001) 160-168
27. Weinrich Olsen A., van Pinxteren L.A., Meng Okkels L., Birk Rasmussen P., and Andersen P. Protection of mice with a tuberculosis subunit vaccine based on a fusion protein of antigen 85b and esat-6. Infect. Immun. 69 (2001) 2773-2778
28. Skeiky Y.A., Alderson M.R., Ovendale P.J., Guderian J.A., Brandt L., Dillon D.C., Campos-Neto A., Lobet Y., Dalemans W., Orme I.M., and Reed S.G. Differential immune responses and protective efficacy induced by components of a tuberculosis polyprotein vaccine, Mtb72F, delivered as naked DNA or recombinant protein. J. Immunol. 172 (2004) 7618-7628